1108658-10-1Relevant articles and documents
Hepatitis C virus inhibitors
-
, (2017/01/23)
Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
MACROCYCLIC SERINE PROTEASE INHIBITORS
-
Page/Page column 109, (2009/03/07)
Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula I, pharmaceutical compositions comprising such compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.